On November 19th, LIVZON PHARMA (01513) spent 32.27 million yuan to repurchase 858,000 shares of A stock.

NPE Holdings (02326) issued a profit warning, expecting a mid-term loss of not more than HK$18 million, compared to a profit in the same period last year.